RTI Surgical (NASDAQ:RTIX) Upgraded by Zacks Investment Research to Hold

Share on StockTwits

Zacks Investment Research upgraded shares of RTI Surgical (NASDAQ:RTIX) from a sell rating to a hold rating in a report issued on Saturday morning, Zacks.com reports.

According to Zacks, “RTI Surgical Inc. is a surgical implant company. Its implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures. RTI Surgical Inc., formerly known as RTI Biologics, Inc., is headquartered in Alachua, Fla. “

Several other research analysts have also issued reports on the stock. ValuEngine lowered shares of RTI Surgical from a buy rating to a hold rating in a report on Thursday, April 2nd. BidaskClub downgraded shares of RTI Surgical from a hold rating to a sell rating in a research report on Saturday, March 7th. Finally, Cantor Fitzgerald began coverage on shares of RTI Surgical in a research report on Monday, June 15th. They set a buy rating and a $5.00 price objective for the company. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company’s stock. The stock currently has a consensus rating of Hold and an average target price of $4.08.

RTI Surgical stock opened at $3.18 on Friday. RTI Surgical has a 52-week low of $1.46 and a 52-week high of $5.40. The firm has a 50 day moving average price of $2.72 and a two-hundred day moving average price of $2.94. The firm has a market cap of $212.61 million, a price-to-earnings ratio of -1.09 and a beta of 2.11.

RTI Surgical (NASDAQ:RTIX) last released its quarterly earnings results on Monday, June 8th. The medical equipment provider reported ($0.16) earnings per share (EPS) for the quarter. RTI Surgical had a positive return on equity of 1.75% and a negative net margin of 68.63%. The firm had revenue of $80.21 million for the quarter. Equities research analysts expect that RTI Surgical will post -0.3 EPS for the current fiscal year.

Several hedge funds have recently made changes to their positions in RTIX. Kopp Family Office LLC acquired a new stake in shares of RTI Surgical during the 4th quarter worth approximately $10,165,000. Wellington Management Group LLP grew its position in RTI Surgical by 24.1% in the 1st quarter. Wellington Management Group LLP now owns 4,060,094 shares of the medical equipment provider’s stock valued at $6,943,000 after purchasing an additional 789,386 shares during the period. Krensavage Asset Management LLC grew its position in RTI Surgical by 11.0% in the 1st quarter. Krensavage Asset Management LLC now owns 4,027,772 shares of the medical equipment provider’s stock valued at $6,887,000 after purchasing an additional 398,809 shares during the period. GABELLI & Co INVESTMENT ADVISERS INC. acquired a new stake in RTI Surgical in the 1st quarter valued at $476,000. Finally, Gabelli Funds LLC grew its position in RTI Surgical by 158.7% in the 1st quarter. Gabelli Funds LLC now owns 310,429 shares of the medical equipment provider’s stock valued at $531,000 after purchasing an additional 190,429 shares during the period. 63.61% of the stock is owned by institutional investors.

RTI Surgical Company Profile

RTI Surgical Holdings, Inc, a surgical implant company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes.

Read More: Futures Contract

Get a free copy of the Zacks research report on RTI Surgical (RTIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.